Fabrication of Data [GxP / QC / QA]

posted by Ohlbe – France, 2007-06-29 13:57 (6940 d 21:29 ago) – Posting: # 846
Views: 5,564

Dear Devender,

First you should inform the sponsor(s) of the trial(s) where you have found problems...

IMHO you should also contact the regulatory authority in charge of overseing (and inspecting) clinical trials in your country. If I understand correctly your "user info" on the forum, you are located in Hyderabad, India, right? I would then suggest to contact CDSCO in Hyderabad (e.g. G. Nageswara Rao, Drugs Inspector, or one of his colleagues) and/or DCGI.

If the manipulations or fabrications may have had an impact on the subjects' safety, or if pre- or post-trial safety assessments were not performed and results fabricated, you should also consider informing the Ethics Committee.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
294 visitors (0 registered, 294 guests [including 15 identified bots]).
Forum time: 11:26 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5